Condition: Charcot Foot · Diabetes Mellitus · Sponsor: Ole Lander Svendsen
The aim of the present trial is to assess the efficacy of treatment of acute Charcot foot in diabetes patients with Prolia® on clinical relevant Outcomes in a randomized, double blind, placebo-controlled trial.
This description comes directly from the study's public registry record.
Ole Lander Svendsen, MD · +4521490547 · Ole.Lander.Svendsen@regionh.dk
Michael Zaucha Sørensen, MD · +4526836584 · mzs@dadlnet.dk
Always discuss trial participation with your own doctor first.
| Steno Diabetes Center North | Aalborg, Denmark | Recruiting |
| Steno Diabetes Center Aarhus | Aarhus, Denmark | Recruiting |
| Bispebjerg Hospital | Copenhagen NV, Denmark | Recruiting |
| Steno Diabetes Center Copenhagen | Gentofte Municipality, Denmark | Recruiting |
| Nordsjællands Hospital | Hillerød, Denmark | Recruiting |
| Hvidovre hospital | Hvidovre, Denmark | Recruiting |
| Zealand University Hospital | Køge, Denmark | Recruiting |
| Steno Diabetes Center Odense | Odense, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04547348